• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » CRO Acquisition Trend Continues as Thermo Fisher Snaps Up PPD

CRO Acquisition Trend Continues as Thermo Fisher Snaps Up PPD

April 19, 2021

The ranks of the top-earning CROs continued to shift last week as Thermo Fisher Scientific announced it will acquire PPD, one of the industry’s largest CROs, for $17.4 billion in cash plus the assumption of about $3.5 billion of net debt.

The deal is the latest to illustrate rising merger and acquisition activity in the CRO sector. In February, ICON announced plans to acquire PRA Health Sciences for $12 billion, making it the second-largest CRO in the world by annual revenue ($5 billion) after IQVIA ($11.4 billion) and moving PPD with its $4.7 billion in revenue from second place to third (CenterWatch Weekly, March 1, 2021).

PPD has more than 26,000 employees and operates in nearly 50 countries, while Thermo Fisher sells lab equipment and supplies to the pharma and biotech industries. PPD will become part of Thermo Fisher’s Laboratory Products and Services segment.

    Upcoming Events

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing